Showing 20 of 34 recruiting trials for “rare-hypercholesterolemia”
The ORIGIN-FH Study
A Dose-exploration Study of EDP167 in HoFH
👨⚕️ Kefei Dou, MD, Chinese Academy of Medical Sciences, Fuwai Hospital📍 1 site📅 Started Feb 2026View details ↗
Study of the Determinants of Coronary Atherosclerosis in Familial Hypercholesterolemia (ATHERO-FH Study)
A Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0616-029)
A Phase 3 Study of Zodasiran in Adolescent and Adult Subjects With Homozygous Familial Hypercholesterolemia (YOSEMITE)
RecruitingNCT06958315 ↗
Inclisiran (Leqvio®) in Patients With Atherosclerotic Vascular Disease and/or Heterozygous Familial Hypercholesterolemia Treated in Spain: the INSPIRE Study
Computerized Decision Support for Identification and Management of Familial Hypercholesterolemia
RecruitingNCT04529967 ↗
Child-Parent Familial Hypercholesterolemia Screening
👨⚕️ LIling Qian, Master, Children's Hospital of Fudan University📍 6 sites📅 Started Apr 2025View details ↗
Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia
RecruitingNCT06634160 ↗
Assessment of the Prevalence of Steatotic Liver Disease Associated With Metabolic Dysfunction in Patients With Heterozygous Familial Hypercholesterolemia
Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia
An Adapted Brazilian Cardioprotective Diet, Phytosterols and Krill Oil in Familial Hypercholesterolemia (DICA-FH)
Atlantic Lipid Lowering Treatment Optimization Program
Enrolling by InvitationNCT06112327 ↗
Long-term Follow-up of Participants Dosed with an Investigational Gene Editing Therapy for Cardiovascular Disease
Clinical Exploration Trial of YOLT-101 in the Treatment of Familial Hypercholesterolemia (FH)
A Study of VERVE-102 in Patients With Familial Hypercholesterolemia or Premature Coronary Artery Disease
Clinical Exploration Trial of YOLT-101 in the Treatment of Familial Hypercholesterolemia (FH)
🏥 The First Affiliated Hospital of Bengbu Medical University📍 1 site📅 Started Apr 2024View details ↗
2-Hydroxybenzylamine (2-HOBA) to Reduce HDL Modification and Improve HDL Function in Familial Hypercholesterolemia (FH)
👨⚕️ MacRae F. Linton, MD, Vanderbilt University Medical Center📍 1 site📅 Started Feb 2024View details ↗
Familial Hypercholesterolemia Interpretive Comment - Nudging to Detection.
👨⚕️ Finn Lund Henriksen, Ph.d., Departement of Cardiology, Odense University Hospital📍 2 sites📅 Started Dec 2023View details ↗
NGGT006 Gene Therapy for Homozygous Familial Hypercholesterolemia
👨⚕️ Zuyi Yuan, M.D., First Affiliated Hospital of Xian Jiaotong University📍 1 site📅 Started Oct 2023View details ↗
Page 1 of 2Next →
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →